Thermo: FEI deal will complement mass spec portfolio 27-May-2016 By Joseph James Whitworth Thermo Fisher Scientific is to buy FEI Company for $4.2bn saying it will drive adoption of FEI’s technologies among its life sciences customers, particularly in biopharma.
Thermo: We have filled a gap for labs using GC-MS 18-Jun-2015 By Joseph James Whitworth Thermo Scientific has claimed it has ‘filled a gap in the market’ for food and pharma labs using GC-MS in terms of sensitivity and selectivity.